Table 5.
In Vitro ADMET Profile for 33
hepatic CLint (µL/mL/min)b | % PPBd | MDCK-MDR1 permeability Papp (×10−6 cm/s) |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
solubilitya | H | R | M | cyno | CYP inhibition (IC50) 2C9, 2C19, 2D6, 3A4 | hERGc (IC50) |
H | R | A-B | B-A | class |
>100 µM | <0.7 | <0.7 | <0.7 | 0.7 | All >34 µM | >30 µM | 99.9 | 99.4 | 74.7 | 82.2 | high permeability |
Kinetic solubility measured in PBS (pH 7.4).
Hepatic intrinsic clearance; H = human; R = rat; M = mouse; cyno = cynomolgus monkey.
Patch-Xpress’ patch-clamp assay; compounds were tested (n = 3) in a five-point concentration–response on HE293 cells stably expressing the hERG channel.
% PPB = plasma protein binding.